News | January 24, 2011

First U.S. Implant Made for System to Treat Central Sleep Apnea

The RespiCardia System is implanted similar to a pacemaker.

January 24, 2011 – The first U.S. clinical implant of a device designed to restore more natural breathing patterns in patients with central sleep apnea was made last week at The Ohio State University Medical Center, Columbus. The procedure was performed by Ralph Augostini, M.D., assistant professor of clinical, cardiovascular medicine, on a 61-year-old male patient with a history of central sleep apnea and atrial fibrillation.

This was the first U.S. implant in a global pilot study of this novel therapy for treating a large and growing health problem. "The first U.S. implant of the RespiCardia System brings concept to reality," said William T. Abraham, M.D., professor of internal medicine and director of cardiovascular medicine at The Ohio State University. "The potential of this therapy is substantial, considering the very high prevalence of central sleep apnea in heart failure patients and in those with various neurological disorders."

It is estimated that about 35-40 percent of all heart failure patients have central sleep apnea. With the incidence of heart failure on the rise, there is even greater emphasis on diagnosing and treating this serious clinical problem.

"The technology has the potential to not only provide a valid alternative to positive pressure devices for the first time, but also to revolutionize the way we diagnose and treat sleep disorders in cardiac patients, " said Rami Khayat, M.D., associate professor of clinical, pulmonary/critical care at The Ohio State University.

The device is made by Cardiac Concepts Inc., which received CE mark approval in August 2010 for its use in Europe. The device is currently in U.S. clinical trials.

For more information visit

Related Content

Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Edwards Intuity Elite sutureless aortic valve, first implants in Connecticut, WCHN, Western Connecticut Health Network
News | Cardiovascular Surgery | February 16, 2017
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were...
Overlay Init